Essent (ESNT) Insider Sells 2,500 Shares Under 10b5-1; Holdings 24,865
Rhea-AI Filing Summary
David B. Weinstock, Senior Vice President and CFO of Essent Group Ltd. (ESNT), reported the sale of 2,500 common shares on 09/15/2025 at a weighted average price of $63.33 per share under a 10b5-1 plan. After the transaction he beneficially owns 24,865 shares. The filing discloses the sale price range ($63.14 to $63.74) and states the reporter will provide a breakdown of quantities sold at each price on request. The Form is signed and dated 09/17/2025.
Positive
- Transaction disclosed under a 10b5-1 plan, indicating the sale was prearranged and intended to satisfy affirmative defense conditions
- Transparent pricing disclosure with a weighted average price and an explicit range ($63.14 to $63.74) and an offer to provide a break-down on request
- Prompt filing and signature (Form signed on 09/17/2025) consistent with Section 16 reporting requirements
Negative
- Insider disposition of 2,500 shares reduces beneficial ownership to 24,865 shares
- No information provided on remaining plan terms such as total shares covered by the 10b5-1 plan or future scheduled transactions
Insights
TL;DR Insider sold a small block of shares under a prearranged 10b5-1 plan; transaction appears routine and transparent.
The sale of 2,500 shares at a weighted average of $63.33 reduces the reporting person’s holdings to 24,865 shares, a clearly disclosed, non-derivative disposition. The use of a 10b5-1 plan and the provision of a price range enhance disclosure quality by clarifying execution timing and prices. For investors, this filing is a routine insider liquidity event rather than a strategic corporate action.
TL;DR Form 4 shows compliant insider reporting with explicit 10b5-1 plan disclosure and willingness to provide detailed trade breakdowns.
The reporter checked the box indicating the transaction was pursuant to a written 10b5-1 plan, which, if valid, provides an affirmative defense against insider trading allegations. The filing includes a weighted average price and a stated range, and the signer attests to the accuracy of the report. Governance-wise, documentation appears consistent with best practices for executive transactions.